Loading...

Home
ETF
PTHS

PTHS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

PTHS News

Horizon Technology Finance Provides $50 Million Loan Facility to Pelthos Therapeutics

Jan 15 2026Newsfilter

Pelthos Therapeutics Secures $30 Million Financing to Accelerate ZELSUVMI Commercialization

Jan 13 2026Globenewswire

Pelthos Appoints Andrew J. Einhorn to Board, Enhancing Financial Management

Dec 23 2025Globenewswire

Pelthos Launches ZELSUVMI, First FDA-Approved At-Home Treatment for Molluscum Contagiosum

Dec 04 2025Globenewswire

Linde Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Wednesday

Dec 03 2025Benzinga

Pelthos Therapeutics Purchases Xepi® (ozenoxacin) Cream, 1%, and Reveals $18 Million Private Convertible Notes Funding

Nov 07 2025Newsfilter

EXCLUSIVE: Pelthos Acquires Antimicrobial Drug Rights and Raises $18 Million for Commercial Launch Support

Nov 07 2025Benzinga

Pelthos Obtains US Rights for Xepi and Secures $18 Million in Funding

Nov 07 2025NASDAQ.COM

Pelthos Therapeutics Set to Attend Investor Conferences This September

Sep 08 2025Newsfilter